Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation. [electronic resource]
- Thyroid : official journal of the American Thyroid Association Apr 2013
- 517-9 p. digital
Publication Type: Letter
1557-9077
10.1089/thy.2012.0614 doi
Humans Protein Kinase Inhibitors--therapeutic use Thyroid Neoplasms--drug therapy